Saturday, 07 December 2024


Avance Clinical Strengthens Asia-Pacific Presence with Strategic MoUs in South Korea for Enhanced Clinical Research Solutions

30 October 2024 | News

Avance Clinical strengthens Asia-Pacific reach with new South Korean partnerships to enhance early-phase clinical trial capabilities and client access to top-tier trial sites.

Yvonne Lungershausen, Avance Clinical CEO, and Young-Sang Kim, Director of CHA Global Clinical Trials Center (CHA University Bundang Medical Center), signed the MOU in Seoul, South Korea.

Yvonne Lungershausen, Avance Clinical CEO, and Young-Sang Kim, Director of CHA Global Clinical Trials Center (CHA University Bundang Medical Center), signed the MOU in Seoul, South Korea.

Avance Clinical, a leading full-service Contract Research Organization (CRO), has announced three pivotal Memorandums of Understanding (MOUs) with major clinical sites in South Korea, signed during the KoNECT 2024 conference. These partnerships mark a significant milestone in Avance Clinical’s strategy to expand its high-quality, agile clinical trial services across the Asia-Pacific region.

Avance Clinical’s CEO, Yvonne Lungershausen, and Asia Regional Director, Jessica Han, formalized these partnerships with CHA University Bundang Medical Center, Korea University Medicine, and Dong-A University Hospital, broadening the CRO’s capabilities in early-phase trials and advancing global therapeutic research.

“These new MOUs further strengthen our mission to provide world-class services to international biotech clients,” said Lungershausen. “As Avance Clinical continues to grow, these partnerships with respected institutions will enhance our ability to offer flexible, efficient, and high-quality clinical trial services in the Asia-Pacific region.”

Jessica Han added, “South Korea’s advanced healthcare infrastructure offers an ideal environment for clinical trials. These partnerships solidify our collaborations and grant clients seamless access to top-tier clinical trial sites and patient populations.”

This development reflects Avance Clinical's commitment to the Asia-Pacific market, reinforced through the partnerships signed at KoNECT 2024, co-hosted by the Korea National Enterprise for Clinical Trials (KoNECT) and the Ministry of Health and Welfare (MOHW).

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account